Research workspace · registry aware
Cancer Research Platform
A pipeline-guided workspace for molecular characterization, evidence exchange, and reproducible research reporting.
Cancer Discovery Pipeline
Seven-stage research framework- Data
- Molecular state
- Biomarkers
- Vulnerabilities
- Pharmacology
- Validation
- Report
Documentation
Contracts, registries, and extension guidance.
Documentation distinguishes the public research journey from the independently versioned project manifests that implement its modules.
Platform references
Core documentation
Start with the architecture contract before adding data, schemas, or project modules.
Module references
Registered manifest documentation
Links are resolved from each web-enabled project manifest.
- P001 · v0.3.0Open declaration
Molecular State Explorer
Research-only molecular-state modeling project with independently versioned task contracts. T001 includes metadata and read-only compatibility validation for the completed legacy TCGA-BRCA TP53 candidate. The current platform specification remains unapproved and cannot pass G0 or produce a release.
- P002 · v0.1.0Open declaration
Cancer Vulnerability Explorer
Contract scaffold for integrating molecular-state evidence with functional, pharmacological, and proteomic evidence to evaluate candidate vulnerabilities. No vulnerability analysis or validation is implemented.
Interpretation guardrails
Research workspace boundaries
- Project registration does not establish analytical completion or scientific validity.
- Planned dataset entries do not imply data access, download, harmonization, or approval.
- Artifact schemas define exchange contracts; only artifact records represent published outputs.
- The platform is not for diagnosis, medical advice, patient-level inference, or clinical decisions.
